{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:22Z","timestamp":1785218422053,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The inflammatory response in cardiac tissue after myocardial infarction (MI) plays a critical role in myocardial injury. Prunetin (PRU), a natural flavonoid compound, has notable anti-inflammatory properties; however, its role in post-MI myocardial injury and the underlying molecular mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Network pharmacology was used to predict potential targets of PRU in MI, identifying TNF-\u03b1 as a high-affinity target. This interaction was further validated by molecular dynamics (MD) simulation and surface plasmon resonance (SPR) assays. A mouse MI model was established to evaluate the protective effects of PRU using echocardiography, histological staining, and serological assays. RNA sequencing was performed to explore the underlying mechanisms, and Western blotting and immunofluorescence were used to assess the TNF-\u03b1\/p38 MAPK\/ERK signaling pathway and pyroptosis-related proteins. R848, a TLR7\/8 agonist, was used to induce TNF-\u03b1 expression and evaluate whether TNF-\u03b1 activation could reverse the protective effects of PRU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments showed that PRU significantly improved cardiac function in MI mice, reduced serum levels of myocardial injury markers, attenuated myocardial fibrosis, and decreased inflammatory cytokine release. PRU also markedly downregulated pyroptosis-related proteins, including NLRP3 and GSDMD-N. Mechanistically, PRU inhibited MI-induced activation of the TNF-\u03b1\/p38 MAPK\/ERK signaling pathway, thereby suppressing cardiomyocyte pyroptosis. R848 reversed the cardioprotective effects of PRU. These findings were further validated in models of damage to cardiac organoids and cardiomyocytes induced by glucose-oxygen deprivation (OGD). Notably, the data on PRU's protective effects in human cardiac organoid models were highly consistent with observations in mice, further reinforcing the clinical relevance and translational potential of this mechanistic hypothesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PRU attenuates post-MI myocardial injury by inhibiting TNF-\u03b1\/p38 MAPK\/ERK signaling, thereby reducing cardiomyocyte pyroptosis and inflammatory responses. These findings provide a theoretical basis for the potential development of PRU as a therapeutic candidate for post-MI myocardial injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1847407","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:38Z","timestamp":1785217058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prunetin ameliorates myocardial pyroptosis after myocardial infarction by inhibiting the TNF-\u03b1\/p38 MAPK\/ERK pathway"],"prefix":"10.3389","volume":"13","author":[{"given":"Huimin","family":"Wu","sequence":"first","affiliation":[{"name":"Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University","place":["Shanghai, China"]},{"name":"The Fifth Clinical Medical College, Anhui Medical University","place":["Anhui, China"]},{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qi","sequence":"additional","affiliation":[{"name":"Neocellmed Co., Ltd.","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University","place":["Shanghai, China"]},{"name":"The Fifth Clinical Medical College, Anhui Medical University","place":["Anhui, China"]},{"name":"Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"664457","DOI":"10.3389\/fimmu.2021.664457","article-title":"Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction","volume":"12","author":"Kologrivova","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation","volume":"33","author":"Algoet","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.it.2023.05.007","article-title":"Cell death checkpoints in the TNF pathway","volume":"44","author":"Huyghe","year":"2023","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0962-8924(01)02064-5","article-title":"Signal transduction by tumor necrosis factor and its relatives","volume":"11","author":"Baud","year":"2001","journal-title":"Trends Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00395-002-0364-9","article-title":"The role of p38 mitogen-activated protein kinase in myocardial ischemia\/reperfusion injury; relationship to ischemic preconditioning","volume":"97","author":"Steenbergen","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25120","DOI":"10.18632\/aging.104106","article-title":"Apelin protects against ischemia-reperfusion injury in diabetic myocardium via inhibiting apoptosis and oxidative stress through PI3K and p38-MAPK signaling pathways","volume":"12","author":"An","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/jmcc.1999.1066","article-title":"Apoptosis is initiated by myocardial ischemia and executed during reperfusion","volume":"32","author":"Freude","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF Biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1652244","DOI":"10.1155\/2022\/1652244","article-title":"Corilagin restrains NLRP3 inflammasome activation and pyroptosis through the ROS\/TXNIP\/NLRP3 pathway to prevent inflammation","volume":"2022","author":"Luo","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00395-011-0204-x","article-title":"Class a scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization","volume":"106","author":"Hu","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCRESAHA.120.318629","article-title":"GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I\/R injury","volume":"129","author":"Shi","year":"2021","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.3390\/ijms252111713","article-title":"Potential anticancer effects of isoflavone prunetin and prunetin glycoside on apoptosis mechanisms","volume":"25","author":"Jeong","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.biopha.2018.07.093","article-title":"Prunetin inhibits lipopolysaccharide-induced inflammatory cytokine production and MUC5AC expression by inactivating the TLR4\/MyD88 pathway in human nasal epithelial cells","volume":"106","author":"Hu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B21","first-page":"199","article-title":"Prunetin inhibits TLR4\/MyD88 pathway to attenuate intestinal epithelial inflammatory response and ameliorate mouse crohn's disease-like colitis]","volume":"40","author":"Li","year":"2024","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70392","DOI":"10.1002\/mco2.70392","article-title":"Gene therapy targeting Pkp2 deficiency attenuates cardiac fibrosis: Insights from single-cell transcriptomics in Pkp2-knockout rats","volume":"6","author":"Ding","year":"2020","journal-title":"MedComm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102184","DOI":"10.1016\/j.gendis.2026.102184","article-title":"Construction and characterization of a cardiac organoid ARVC disease model with its application in gene therapy targeting PKP2","author":"Zhu","year":"2026","journal-title":"Genes & Diseases"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1611342","DOI":"10.3389\/fphar.2025.1611342","article-title":"Machine learning analysis of ARVC informed by sodium channel protein-based interactome networks","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: jACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"114036","DOI":"10.1016\/j.intimp.2025.114036","article-title":"Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway","volume":"147","author":"Lai","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molimm.2022.12.002","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b2 triggers human airway epithelial cells death by apoptosis and pyroptosis","volume":"153","author":"Sun","year":"2023","journal-title":"Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.smim.2023.101809","article-title":"Pyroptosis in cardiovascular diseases: pumping gasdermin on the fire","volume":"69","author":"Yarovinsky","year":"2023","journal-title":"Semin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70418","DOI":"10.1002\/mco2.70418","article-title":"Acute myocardial infarction: molecular pathogenesis, diagnosis, and clinical management","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm (2020)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13436","DOI":"10.1111\/imr.13436","article-title":"MAP Kinase signaling at the crossroads of inflammasome activation","volume":"329","author":"Vervaeke","year":"2025","journal-title":"Immunol Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4049\/jimmunol.2000416","article-title":"P38 MAPK activity is required to prevent hyperactivation of NLRP3 inflammasome","volume":"207","author":"Shin","year":"2021","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1074\/jbc.C100685200","article-title":"MK2 Targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels","volume":"277","author":"Neininger","year":"2002","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.4049\/jimmunol.1801221","article-title":"The role of TTP phosphorylation in the regulation of inflammatory cytokine production by MK2\/3","volume":"203","author":"Ronkina","year":"2019","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.4049\/jimmunol.1301974","article-title":"Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function","volume":"192","author":"Ghonime","year":"2014","journal-title":"J Immunol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1847407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:39Z","timestamp":1785217059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1847407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2026.1847407"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1847407","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1847407"}}